First Pediatric Pharmacotherapy Symposium

Introduction

Take This Event

The first pediatric pharmacotherapy Symposium is aimed to:
• To provide a platform for researchers, pediatricians, pharmacists, and healthcare professionals to share the latest research, findings, and best practices in pediatric pharmacotherapy.
• To enhance the knowledge and skills of attendees by offering educational sessions, workshops, and presentations on various aspects of pediatric pharmacotherapy, including dosage guidelines, drug interactions, medication safety, and age-specific considerations.
• To promote the use of evidence-based practices in pediatric pharmacotherapy by highlighting the latest research evidence, clinical guidelines, and recommendations for pediatric drug use.
• To explore the latest advancements in pediatric pharmacotherapy, including novel drug therapies, personalized medicine approaches, pharmacogenomics, and innovative drug delivery systems.

Objectives

• To provide a platform for researchers, pediatricians, pharmacists, and healthcare professionals to share the latest research, findings, and best practices in pediatric pharmacotherapy, with a specific focus on evidence-based approaches and emerging therapies.
• To foster collaboration and networking opportunities among attendees, aiming to facilitate at new research collaborations and partnerships in pediatric pharmacotherapy.
• To offer a minimum of 7 educational sessions, workshops, and presentations on various aspects of pediatric pharmacotherapy, ensuring attendees gain new knowledge and skills specific to pediatric drug use, dosage guidelines, and medication safety.
• To explore the latest advancements in pediatric pharmacotherapy, the conference will feature speakers and sessions highlighting at least five emerging therapies and innovations specific to pediatric patients.
• By the end of the conference, attendees will have gained insights into therapies and innovations in pediatric pharmacotherapy, including gene therapy, pharmacotherapy updates, and innovative drug therapy approach.